- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2008
- Public Summary Document (PSD) March 2008 PBAC Meeting - PDF
Sorafenib tosylate – March 2008
Sorafenib tosylate, tablet, 200 mg (base), Nexavar, March 2008
Last updated
4 July 2008
